Table 1:

Characteristics of 9285 participants in the Finnish Public Sector Study who began statin therapy after completing the survey

CharacteristicNo. (%) of participants
All
n = 9285
Without cardiovascular comorbidities*
n = 6458
With cardiovascular comorbidities*
n = 2827
Sex
Male2211 (23.8)1430 (22.1)781 (27.6)
Female7074 (76.2)5028 (77.9)2046 (72.4)
Age group, yr
24–501971 (21.2)1444 (22.4)527 (18.6)
51–604811 (51.8)3344 (51.8)1467 (51.9)
61–752503 (27.0)1670 (25.9)833 (29.5)
Education
High4363 (47.0)3185 (49.3)1178 (41.7)
Intermediate3390 (36.5)2311 (35.8)1079 (38.2)
Basic1532 (16.5)962 (14.9)570 (20.2)
Marital statusn = 9144n = 6365n = 2779
Married6976 (76.3)4835 (76.0)2141 (77.0)
Single2168 (23.7)1530 (24.0)638 (23.0)
Residential region in Finlandn = 9260n = 6438n = 2822
Southern5587 (60.3)4014 (62.3)1573 (55.7)
Central1947 (21.0)1344 (20.9)603 (21.4)
Northern1726 (18.6)1080 (16.8)646 (22.9)
Suboptimal self-rated healthn = 9184n = 6394n = 2790
No5315 (57.9)3983 (62.3)1332 (47.7)
Yes3869 (42.1)2411 (37.7)1458 (52.3)
Cancern = 9285n = 6458n = 2827
No9110 (98.1)6329 (98.0)2781 (98.4)
Yes175 (1.9)129 (2.0)46 (1.6)
Use of antidepressants
No7547 (81.3)5253 (81.3)2294 (81.1)
Yes1738 (18.7)1205 (18.7)533 (18.9)
  • * Hypertension, heart failure, coronary artery disease, diabetes, stroke or arrhythmias.